Patent · US Active

Fospropofol salts, methods and compositions

US11547714B2 · kind B2 · utility

1Cited by
20References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2021
Grant dateJan 10, 2023
Priority date—
Expiry dateFeb 5, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure pertains to pharmaceutically acceptable salts of fospropofol and their use to treat migraine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.